Walker Paul Edward

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$102.41M
Insider Sells Quantity
3
Insider Sells Sum
$29.23M

Insider Activity of Walker Paul Edward

According to the SEC Form 4 filings, Walker Paul Edward, being in a position of

  1. 10 percent owner at Korro Bio, Inc.,
    оver the last 12 months, has bought 17857 shares for $999,992, and sold 0 shares,
    over all time since 2024-04-22, has bought 17857 shares for $999,992, and sold 0 shares.

The largest purchase of all time was on 2019-05-09 and amounted to 5000000 shares of Trevi Therapeutics, Inc. for $50M.

The largest sale of all time was on 2020-12-30 and amounted to 136784 shares of Allakos Inc. for $19.38M.

Biography of Walker Paul Edward

No biography is available at this moment.

2024-04-22PurchaseKorro Bio, Inc.
KRRO
10 percent owner
17,857
0.205%
$56.00$999,992-31.3%
2023-07-17PurchaseSavara Inc.
SVRA
10 percent owner
333,333
0.2084%
$3.00$999,999+32.17%
2021-10-18PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
1.85M
11.1305%
$1.62$3M+63.35%
2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
1.05M
20.5778%
$19.00$19.95M-7.95%
2021-03-16PurchaseMarker Therapeutics, Inc.
MRKR
10 percent owner
5.71M
9.5207%
$1.75$10M-4.3%
2020-12-31SaleAllakos Inc.
ALLK
director
70,046
0.1321%
$140.46$9.84M-28.14%
2020-12-30SaleAllakos Inc.
ALLK
director
136,784
0.2667%
$141.71$19.38M-28.63%
2020-12-04PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
4.4M
7.578%
$0.62$2.74M+22.37%
2020-04-03SaleTrevi Therapeutics, Inc.
TRVI
10 percent owner
1,128
0.0062%
$2.66$3,000+19.07%
2019-07-22PurchaseMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
900,000
5.3814%
$15.00$13.5M+5.09%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
5M
34.6117%
$10.00$50M-42.9%
2019-05-07PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
1.14M
6.1239%
$1.08$1.23M-40%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.